Katakura Industries (3001) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Mar, 2026Executive summary
Revenue for Q1 FY2025 was ¥11,255 million, up 6.6% year-over-year, driven by strong machinery segment sales despite a decline in pharmaceuticals.
Operating income rose 71.7% to ¥1,696 million, and net income attributable to shareholders increased 41.2% to ¥1,347 million year-over-year.
The company continued structural reforms and investments in growth areas, focusing on real estate, functional fibers, and machinery.
Financial highlights
Gross profit increased to ¥3,838 million from ¥3,736 million year-over-year.
Operating margin improved significantly, with operating income at ¥1,696 million versus ¥987 million last year.
Net assets stood at ¥88,198 million, with a 62.3% equity ratio.
Comprehensive income dropped sharply to ¥155 million from ¥2,691 million year-over-year due to valuation losses.
Outlook and guidance
Full-year revenue forecast remains unchanged at ¥40,600 million, with operating income projected at ¥4,600 million and net income at ¥4,000 million.
No revision to previously announced guidance; management notes ongoing economic uncertainties.
Latest events from Katakura Industries
- Revenue fell 4.7% YoY, with stable operating profit and ongoing pharma restructuring.3001
Q2 202420 Mar 2026 - Revenue and profit fell on machinery and textile weakness, but real estate grew; dividend raised.3001
Q3 202420 Mar 2026 - Operating and net income rose despite lower sales, with higher dividends and FY2025 growth forecast.3001
Q4 202420 Mar 2026 - Net income nearly doubled on strong machinery sales and asset gains; full-year outlook raised.3001
Q2 202520 Mar 2026 - Net income surged 90.4% year-over-year, driven by machinery gains and asset sales.3001
Q3 202520 Mar 2026 - Strong profit growth driven by machinery and real estate; cautious FY2026 outlook.3001
Q4 202520 Mar 2026